Boothbay Fund Management’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,579
Closed -$99.3K 2409
2022
Q4
$99.3K Buy
+3,579
New +$136K ﹤0.01% 1788
2021
Q3
Sell
-758
Closed -$35K 2105
2021
Q2
$35K Buy
+758
New +$38.7K ﹤0.01% 1792
2019
Q4
Sell
-1,740
Closed -$183K 947
2019
Q3
$183K Buy
+1,740
New +$174K 0.02% 658

Other funds holding OPTN

Boothbay Fund Management's OPTN Position: Q1 2023 in Review

Boothbay Fund Management sold out of OptiNose (OPTN) in Q1 2023, closing a stake of 3,579 shares — an estimated $99.3K sold.

Boothbay Fund Management first reported a position in OPTN in Q3 2019 and held it in 3 quarters. The position peaked at $183K in Q3 2019. 62 funds tracked by Wall St. Rank hold OPTN as of Q1 2023.

  • Boothbay Fund Management reported no remaining OptiNose position as of Q1 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 3,579 OptiNose shares in Q1 2023, an estimated $99.3K.
  • Boothbay Fund Management first reported a position in OptiNose in Q3 2019 and held it in 3 quarters.
  • Boothbay Fund Management's OptiNose position peaked at $183K in Q3 2019.
  • 62 funds tracked by Wall St. Rank held OptiNose as of Q1 2023.

Based on Boothbay Fund Management's 13F filing for Q1 2023, filed 15 May 2023.